Rallybio Corporation announced that it has appointed Wendy K. Chung, M.D., Ph.D., to its Board of Directors.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.67 USD | +5.03% | +7.05% | -30.13% |
05-15 | JPMorgan Downgrades Rallybio to Neutral From Overweight | MT |
05-09 | Rallybio Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-30.13% | 69.22M | |
+43.36% | 54.64B | |
-5.31% | 39.92B | |
+37.52% | 38.82B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+25.12% | 12.21B | |
+0.04% | 12.16B | |
+26.04% | 11.94B |
- Stock Market
- Equities
- RLYB Stock
- News Rallybio Corporation
- Rallybio Corporation Appoints Wendy K. Chung, M.D., Ph.D., to Its Board of Directors